An overall goal of this application is understanding the structure/function relationships of coagulation proteins. We propose to make directed mutations of coagulation factor X. These mutations will derive from the molecular models being constructed as part of another subproject of this Program Project. Also, a key question in this grant is the extent to interactions amongst proteins, as opposed to purely phospholipids, regulate the coagulation system. We are specifically interested in the ways in which platelet surface thrombin generation is regulated. For a number of these studies we will use a model system of coagulation that has been developed in our lab. This system uses cellular tissue factor, unactivated platelets, plasma concentrations of coagulation factors and inhibitors. In this system, platelets are activated before coagulation complexes assemble on the activated platelets leading to a burst of thrombin generation. Looking at thrombin generation on platelets from different individuals, we have observed that there are significant, reproducible differences. Also, thrombin generation can be significantly altered by altering the conditions under which platelets are activated. We will use the differences between individuals and the differences seen as a function of activation conditions as tools to allow us to identify components important in promoting the controlled procoagulant activity of platelets. We are also specifically interested in characterizing two specific regulatory proteins: the platelet factor IX binding protein and the endothelial cell factor IX binding protein. In a previous cycle of this PPG, a tight binding site for factor IX was identified on type IV collagen. Since luminal exposure of type IV collagen seems unlikely, we speculate that this type IV collagen domain is a motif that is being reused and propose to determine the nature of the endothelial cell factor IX binding protein.

National Institute of Health (NIH)
National Heart, Lung, and Blood Institute (NHLBI)
Research Program Projects (P01)
Project #
Application #
Study Section
Heart, Lung, and Blood Initial Review Group (HLBP)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of North Carolina Chapel Hill
Chapel Hill
United States
Zip Code
Bode, Michael F; Mackman, Nigel (2016) A combined deficiency of tissue factor and PAR-4 is associated with fatal pulmonary hemorrhage in mice. Thromb Res 146:46-50
Boulaftali, Yacine; Owens 3rd, A Phillip; Beale, Ashley et al. (2016) CalDAG-GEFI Deficiency Reduces Atherosclerotic Lesion Development in Mice. Arterioscler Thromb Vasc Biol 36:792-9
Owens 3rd, A Phillip; Edwards, Todd L; Antoniak, Silvio et al. (2015) Platelet Inhibitors Reduce Rupture in a Mouse Model of Established Abdominal Aortic Aneurysm. Arterioscler Thromb Vasc Biol 35:2032-2041
Wu, Sangwook; Lee, Chang Jun; Pedersen, Lee G (2014) Analysis on long-range residue-residue communication using molecular dynamics. Proteins 82:2896-2901
Bode, Michael; Mackman, Nigel (2014) Regulation of tissue factor gene expression in monocytes and endothelial cells: Thromboxane A2 as a new player. Vascul Pharmacol 62:57-62
Wu, Sangwook; Beard, William A; Pedersen, Lee G et al. (2014) Structural comparison of DNA polymerase architecture suggests a nucleotide gateway to the polymerase active site. Chem Rev 114:2759-74
Perera, Lalith; Beard, William A; Pedersen, Lee G et al. (2014) Applications of quantum mechanical/molecular mechanical methods to the chemical insertion step of DNA and RNA polymerization. Adv Protein Chem Struct Biol 97:83-113
Parker, Christine H; Morgan, Christopher R; Rand, Kasper D et al. (2014) A conformational investigation of propeptide binding to the integral membrane protein ?-glutamyl carboxylase using nanodisc hydrogen exchange mass spectrometry. Biochemistry 53:1511-20
Boulaftali, Yacine; Hess, Paul R; Getz, Todd M et al. (2013) Platelet ITAM signaling is critical for vascular integrity in inflammation. J Clin Invest 123:908-16
Mutoh, Shingo; Sobhany, Mack; Moore, Rick et al. (2013) Phenobarbital indirectly activates the constitutive active androstane receptor (CAR) by inhibition of epidermal growth factor receptor signaling. Sci Signal 6:ra31

Showing the most recent 10 out of 57 publications